Viewing Study NCT06441968

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2026-07-21 @ 4:01 AM
Study NCT ID: NCT06441968
Status: COMPLETED
Last Update Posted: 2025-11-14
First Post: 2024-05-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adults View
None MPV/S-2P View
None phase 1 View
None SARS-CoV-2 View
None trial View
None vaccine View